XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2024
Stock-Based Compensation  
Stock-Based Compensation

(8)  Stock-Based Compensation

A summary of stock option activity for the three months ended March 31, 2024 is as follows:

Weighted

Weighted

Average

Average

Exercise

Remaining

Price

Contractual

    

Shares

    

Per Share

    

Term (In Years)

Options outstanding at December 31, 2023

 

6,378,924

$

29.69

7.5

Granted

 

5,000

$

37.08

Exercised

 

(222,619)

$

16.27

Canceled

 

(2,568)

$

83.21

Options outstanding at March 31, 2024

 

6,158,737

$

30.16

7.4

Options vested and expected to vest at March 31, 2024

 

6,065,176

$

30.14

7.3

Options exercisable at March 31, 2024

 

3,284,980

$

29.45

6.3

Shares available for grant under the 2021 Plan

 

1,011,071

The weighted average grant-date fair value of stock options granted during the three months ended March 31, 2024 was $28.64.

The aggregate intrinsic value of stock options vested and expected to vest at March 31, 2024 was $104.1 million. The aggregate intrinsic value of stock options exercisable at March 31, 2024 was $74.3 million. As of March 31, 2024, total compensation cost related to non-vested employee, consultant and non-employee director stock options not yet recognized was approximately $55.3 million, net of estimated forfeitures, which is expected to be recognized as expense over a weighted average period of 2.4 years.

Stock-based compensation expense for the three months ended March 31, 2024 and 2023 was recorded as follows:

Three Months Ended March 31, 

    

2024

    

2023

(In thousands)

Research and development

$

3,693

$

2,162

General and administrative

 

3,509

 

2,178

Total stock-based compensation expense

$

7,202

$

4,340

The fair values of employee, consultant and non-employee director stock options granted during the three months ended March 31, 2024 and 2023 were valued using the Black-Scholes option pricing model with the following assumptions:

Three Months Ended March 31, 

    

    

2024

    

2023

Expected stock price volatility

 

92%

92%

Expected option term

 

6.0 Years

6.0 Years

Risk-free interest rate

 

4.0 – 4.3%

3.7 – 4.0%

Expected dividend yield

 

None

None